What should your lab know about direct-to-consumer genetic testing? What role should labs play in whole-genome sequencing performed for health screening?

The PGS test and the FDA’s subsequent order of 23andMe to cease marketing the test to consumers has stirred controversy, and brought focus to an issue labs may have to face sooner rather than later: What role should labs play in whole-genome sequencing performed for health screening?

More news on FDA 23 and Me ( Click on this link for Dec 2014 news below):

Last week, it was announced that the Google-associated home DNA screening kit, 23andMe will be launched in the UK. In the US, however, 23andMe remains unavailable – a Food and Drug Administration order issued in November 2013 instructed the company to desist from marketing their eponymous genomics kit in the US. We investigate the issue.
Advertisements

One thought on “What should your lab know about direct-to-consumer genetic testing? What role should labs play in whole-genome sequencing performed for health screening?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s